Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders

NCT00551200 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen